The Multiple Myeloma Therapy Market is developing as pharmaceutical companies and healthcare providers continue to advance treatment options for multiple myeloma, a cancer of plasma cells in the bone marrow. The therapeutic landscape includes targeted medicines, immunomodulatory agents, proteasome inhibitors, monoclonal antibodies, corticosteroids, chemotherapy, and stem cell transplantation...